Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

MEK1/2

MEK1/2, also known as MAPKK (mitogen-activated protein kinase kinase), is a kinase enzyme which phosphorylates MAPK (mitogen-activated protein kinase).

Items 31-37 of 37

Page
per page
  1. Trametinib (GSK1120212)
    A3018 Trametinib (GSK1120212)
     7 Citation
    Target: MEK
    Summary: MEK1 and MEK2 inhibitor, potent and selective
      insoluble in H2O; insoluble in EtOH; ≥15.38 mg/mL
  2. Cobimetinib
    A3321 Cobimetinib
     3 Citation
    Summary: Selective MEK inhibitor
      ≥26.55 mg/mL
  3. Cobimetinib (racemate)
    A3322 Cobimetinib (racemate)
    Summary: Selective MEK inhibitor
      Soluble in DMSO
  4. Cobimetinib (R-enantiomer)
    A3323 Cobimetinib (R-enantiomer)
    Summary: Selective MEK inhibitor
      Soluble in DMSO
  5. MEK inhibitor
    A3594 MEK inhibitor
    Summary: Potent MEK inhibitor, Antitumor agent
      Soluble in DMSO
  6. SCH772984
    A3805 SCH772984
     7 Citation
    Summary: ERK1 and ERK2 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥14.7 mg/mL
  7. Trametinib DMSO solvate
    A3887 Trametinib DMSO solvate
     1 Citation
    Target: MEK
    Summary: Allosteric MEK1/MEK2 kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥11.2 mg/mL

Items 31-37 of 37

Page
per page